Skip to main content

Effects of gold nanoparticles combined with human β-defensin 3 on the alveolar bone loss of periodontitis in rat

Abstract

Background

Nanomaterials of biomedicine and tissue engineering have been proposed for the treatment of periodontitis in recent years. This study aimed to investigate the effects of gold nanoparticles (AuNPs) combined with human β-defensin 3 (hBD3) on the repair of the alveolar bones of experimental periodontitis in rats.

Methods

A model of experimental periodontitis was established by ligation of the maxillary second molars with silk thread in rats, which were treated with or without AuNPs combined with hBD3. Micro‐computerized tomography (micro-CT) scanning, enzyme-linked immunosorbent assay, and histological and immunohistochemical staining, including alkaline phosphatase (ALP), osteoprotegerin (OPG), tartrate-resistant acid phosphatase (TRAP), and receptor activator of NF-κB ligand (RANKL), were used to analyze the samples.

Results

Micro-CT demonstrated that the alveolar bone resorption was significantly reduced after the treatment with AuNPs combined with hBD3. Levels of TNF-α and IL-6 were decreased markedly compared with the ligation group. H&E and Masson staining showed that AuNPs combined with hBD3 group had less inflammatory cell infiltration, collagen fibrosis and fracture, but higher calcification in the new bone tissue. Moreover, the administration of AuNPs combined with hBD3 increased the expression levels of ALP and OPG (related to bone formation) while decreasing the expression levels of TRAP and RANKL (related to bone resorption) expression.

Conclusions

AuNPs combined with hBD3 had a protective effect on the progression of experimental periodontitis in rats and played a certain role in suppressing osteoclastogenesis and alleviating the inflammatory destruction of periodontitis along with the promotion of bone repair.

Background

Periodontitis is a chronic infectious disease that occurs in periodontal supporting tissues. As one of the most common oral diseases, it can cause the destruction of the periodontal supporting tissues and eventually contribute to tooth loss [1]. The purpose of periodontitis treatment is to control infection and promote tissue regeneration. However, the effects of tissue regeneration by current periodontal treatments, including scaling and root planing, periodontal flap surgery, and guided tissue regeneration, are limited [2, 3]. In addition, drug therapy is also associated with certain problems, such as drug resistance and flora imbalance, and it is difficult to promote tissue repair and regeneration [4, 5]. Therefore, it is necessary to seek new treatment methods for the disease.

Human β-defensin 3 (hBD3) is one of the most broad-spectrum, antibacterial and cationic defensins in the beta-defensins family [6]. A study in 2018 demonstrated that hBD3 could promote the healing of bacteria-contaminated bone defects in rats [7]. Moreover, Zhu et al. showed that hBD3 might function as an osteogenic promoter to regenerate periodontal tissues in a dog model of periodontitis [8]. However, due to its short half-life and easy hydrolysis characteristics, hBD3 is usually difficult to apply directly. Therefore, the use of new biocompatible materials, such as nanoparticles, has recently been attempted to improve outcomes.

Gold nanoparticles (AuNPs), in view of their ease of synthesis, characterization, and surface functionalization, are recognized as novel nanomaterials in drug delivery, diagnosis, and therapy [9]. Studies have confirmed that AuNPs can be used as anti-inflammatory and antitumor drugs [10, 11]. In addition, AuNPs have always played a pivotal role in bone regeneration engineering. Recent studies demonstrated that AuNPs could promote the repair of alveolar bone defects via cell sheet technology [12]. In addition, AuNPs could regulate the macrophage phenotype to produce a microenvironment with restricted inflammatory cytokine levels and repair cytokines, such as bone morphogenetic protein 2 (BMP-2), thereby promoting periodontal tissue regeneration and preventing the progression of periodontitis [13].

Our previous studies suggested that hBD3 combined with AuNPs could promote the osteogenic differentiation of human periodontal ligament cells [14]. However, the synergistic effects of AuNPs and hBD3 in vivo remain unknown. Therefore, based on the results of previous studies, this study continues to explore whether hBD3 combined with AuNPs can reduce periodontal inflammation and alveolar bone resorption in experimental periodontitis in rats and further investigates the possible mechanism involved in this process.

Results

Effects of AuNPs combined with hBD3 on alveolar bone resorption in the SD rats with experimental periodontitis

The absorption of alveolar bone in SD rats was detected by micro‐computerized tomography (micro-CT). The micro-CT results showed that the alveolar bones of the NaCl + ligation group were significantly absorbed after 14 days, indicating that an experimental periodontal model was successfully established. As shown in Fig. 1a, the degree of alveolar bone resorption of the maxillary second molars in the AuNPs-hBD3 + ligation group was significantly lower than those in the NaCl + ligation group, the hBD3 + ligation group, and the AuNPs + ligation group. In addition, as shown in Fig. 1b, analyses of bone mineral density (BMD), bone volume (BV), and relative bone volume fraction (BV/TV) revealed significantly higher levels in the AuNPs-hBD3 + ligation group than in the other groups, and the tissue volume (TV) of the AuNPs-hBD3 + ligation group was notably lower than that of the other groups.

Fig. 1
figure1

Effects of AuNPs combined with hBD3 on alveolar bone loss. a The view of the alveolar bone level was shown by micro-CT through three-dimensional reconstruction images; b The BMD (bone mineral density), BV (bone volume), bone fraction (BV/TV) and TV (tissue volume) in the interradicular regions of the second maxillary molars of each group (n = 5 per group). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, compared with the NaCl + ligation group. #P < 0.05, ##P < 0.01, ###P < 0.001

Effects of AuNPs combined with hBD3 on serum inflammatory factors in SD rats

To further prove the role of hBD3 combined with AuNPs in experimental periodontitis, the concentrations of TNF-α, IL-6, and IFN-γ in serum were detected by enzyme-linked immunosorbent assay (ELISA). As shown in Fig. 2a and b, the expression levels of TNF-α and IL-6 in the NaCl + ligation group were significantly upregulated, indicating that inflammation stimulated the secretion, while the AuNPs-hBD3 + ligation group had significantly reduced serum TNF-α and IL-6 levels. However, as shown in Fig. 2c, the expression of IFN-γ in the NaCl + ligation group was downregulated, while its expression in the hBD3 + AuNPs + ligation group was significantly upregulated.

Fig. 2
figure2

Effects of AuNPs combined with hBD3 on the inflammation profile. ELISA kits were used to measure the serum levels of TNF-α (a), IL-6 (b), and IFN-γ (c). *P < 0.05, **P < 0.01, ***P < 0.001, compared with the NaCl + ligation group. ##P < 0.01, ###P < 0.001

Histological examination of rat maxilla treated with AuNPs combined with hBD3

Based on H&E and Masson staining of the rat maxilla, the effects of AuNPs combined with hBD3 on experimental periodontitis were further verified from a histological point of view.

H&E staining (Fig. 3a) revealed that the periodontal ligament (PDL) in the interproximal area was healthy and that there was no attachment loss in the NaCl group. The NaCl + ligation group showed loss of the interdental papilla and apical migration of the junctional epithelium. Disorganization and disruption of collagen fibers and the presence of moderate to severe mononuclear inflammation in the subepithelial connective tissue and at the margins of the periodontal ligament were also observed. However, the AuNPs-hBD3 + ligation group showed fewer signs of severe inflammation and PDL destruction than the NaCl + ligation group, the AuNPs + ligation group, and the hBD3 + ligation group.

Fig. 3
figure3

Histological examination of periodontal tissues measured by AuNPs combined with hBD3. a H&E staining (× 40), b Masson staining (× 40) (C, tooth crown; R, tooth root; AB, alveolar bone; PDL, periodontal ligament)

Masson staining (Fig. 3b) revealed that in the NaCl group, the trabecular bone structure was tight, the muscle fibers were stained deeply and obviously, the Havers system structure was obvious, and the bone maturity was high. In the NaCl + ligation group, there were more blue collagen fibers, which indicated that low calcification of the alveolar bone. The Havers system was still in the initial formation stage. However, compared with the NaCl + ligation group, these damages were apparently recovered via combination treatment with AuNPs and hBD3. The Havers system in the new bone tissue was more mature and similar to that of a normal jaw bone tissue structure.

TRAP and ALP staining of rat maxilla treated with AuNPs combined with hBD3

The effects of hBD3 combined with AuNPs on experimental periodontitis were also determined by observing the numbers of osteoclasts and osteoblasts.

As shown in Fig. 4a and c, there were a number of cells with positive TRAP staining in the alveolar bone in the NaCl + ligation group, indicating active osteoclasts, while there were relatively few TRAP-positive cells in the AuNPs combined with hBD3 group on the surface of the alveolar bone, suggesting that the bone resorption activity was weaker. In contrast, the ALP expression of the AuNPs combined with hBD3 group was markedly increased in the periosteum of the alveolar bone, while it was weak in the control group (Fig. 4b and d).

Fig. 4
figure4

TRAP and ALP staining of periodontal tissues measured by AuNPs combined with hBD3. a TRAP staining images (red arrows indicate osteoclasts that were dyed red) (× 400). b ALP staining images (× 400). The corresponding quantitative analysis of the osteoclast number (c) and ALP expression (d) in periodontal tissues. ***P < 0.001, compared with the NaCl + ligation group. #P < 0.05, ###P < 0.001

OPG and RANKL staining of rat maxilla treated with AuNPs combined with hBD3

Finally, we evaluated OPG and RANKL expression to further confirm the interventional effects of AuNPs combined with hBD3 on experimental periodontitis.

OPG immunostaining showed mild staining in the periodontium of rats in the NaCl + ligation group, while moderate staining (in light brown) was observed, indicating bone formation in the AuNPs-hBD3 + ligation group (Fig. 5a and c).

Fig. 5
figure5

OPG and RANKL staining of periodontal tissues measured by AuNPs combined with hBD3. a OPG staining (red arrows indicate osteoblasts that were dyed brown) (× 400) and b RANKL staining (× 400). Corresponding quantitative analysis of OPG expression (c) and RANKL expression (d) in periodontal tissues. *P < 0.05, **P < 0.01, ***P < 0.001, compared with the NaCl + ligation group. ##P < 0.01, ###P < 0.001

Compared with the NaCl group, the periodontium of rats subjected to ligation showed marked immunostaining of RANKL (in dark brown). However, AuNPs combined with hBD3 reduced bone resorption in the periodontium of rats subjected to ligation (Fig. 5b and d).

Discussion

In recent years, several studies have shown that the destruction of periodontal tissue is closely related to the immune response [15]. With the in-depth understanding of the pathogenesis of periodontitis, the interactions among the host immune response, bacteria, and microorganisms and the environment have been found to be crucial in the occurrence and development of periodontitis and the regeneration of periodontal tissues [16]. hBD3 mediated a range of antibacterial biological activities against a broad spectrum of pathogenic microbes by destroying the membrane and forming pores in the plasma membranes of pathogens [17]. In addition, hBD3 can promote periodontal regeneration as sites of infection [7, 18]. However, hBD3 is difficult to widely apply to treatment because of its short half-life and easily hydrolyzed characteristics. AuNPs are widely used as carriers and easily modify the surfaces of polypeptide molecules by physical and chemical techniques, which could compensate for the shortcomings of polypeptide molecules that are easily degraded by proteases and could also take advantage of the carrier to enter cells through receptor-mediated endocytosis [19]. Therefore, AuNPs are considered to be an excellent carrier for the high-efficiency transmembrane transport of extracellular substances. In our study, considering the potential synergistic therapeutic effects of modified AuNPs and peptides, hBD3 was combined with AuNPs and showed more significant effects on the treatment of periodontitis than hBD3 or AuNPs, respectively. Studies have shown that nanoparticles modified with functional peptides can successfully target the cell membrane, enter the cell across the membrane, and even be transported to organelles, such as the nucleus and mitochondria [19,20,21]. Notably, functional peptides, which play an important role in the interaction between nanoparticles and cells, are also essential to the behavior and distribution of the intracellular transport of nanoparticles [22, 23].

In the periodontal inflammatory microenvironment, lipopolysaccharide (LPS) interacts with monocytes to produce a variety of cytokines that function in classic pathways of periodontitis bone destruction, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6); it also plays important roles in the progression of periodontitis. In this study, the concentrations of TNF-α and IL-6 in rat serum were determined by ELISA. The results showed that the expression levels of TNF-α and IL-6 in serum increased significantly following ligation. After treatment with AuNPs combined with hBD3, the levels decreased significantly compared with the ligation group, indicating that AuNPs combined with hBD3 could significantly reduce periodontal inflammation. Previous studies confirmed that the expression levels of TNF-α and IL-6 were positively correlated with the severity of periodontitis, which was significantly increased at the site of periodontal inflammation, and its level was significantly reduced after treatment. Therefore, these cytokines could be used as the evaluation index for the degree of periodontal tissue damage [24,25,26].

The clinicopathological features of chronic periodontitis mainly include the formation of periodontal pockets, alveolar bone resorption, tooth mobility, and tooth loss in the terminal stage. In our study, micro-CT was used to detect the effects of alveolar bone resorption in the rat maxillary second molars. The results showed that there were obvious alveolar bone resorption images at the root furcation of the second molars in the NaCl + ligation group, and alveolar bone resorption was significantly reduced after treatment with AuNPs and hBD3. The analysis of bone parameter-related indicators, including bone mineral density (BMD), bone volume (BV), and relative bone volume fraction (BV/TV), indicated that AuNPs combined with hBD3 effectively contributed to bone formation.

H&E staining showed that compared with the control group, the AuNPs combined with hBD3 group had less inflammatory cell infiltration and less collagen fibrosis and fracture. Masson staining depicted that the AuNPs combined with hBD3 group had obvious red staining and higher calcification in the new bone tissue. Furthermore, ALP and TRAP play a critical roles in osteogenesis as key enzymes involved in the processes of bone matrix deposition and resorption [27]. ALP is unique to osteoblasts and pre-osteoblasts, whereas osteocytes do not secrete ALP, while TRAP is secreted by osteoclasts [28]. In our study, the administration of AuNPs combined with hBD3 increased the expression of ALP while decreasing TRAP expression. Similar effects were observed in MG-63 cells and MC3T3E-1 cells treated with human beta-defensins and gold nanoclusters, respectively [29, 30].

In further research, we continued to explore the mechanism by which AuNPs combined with hBD3 protected periodontitis. During the process of bone reconstruction, osteoclasts and osteoblasts maintain certain numbers to restrict each other and are renewed to keep balance [31]. Osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) are among the most critical cytokines in this regulation. RANKL is the main regulator of bone resorption. Various cytokines, inflammatory mediators, and hormones indirectly mature and activate osteoclasts mainly by promoting the secretion of RANKL. OPG is the receptor of RANKL; by binding to RANKL, it can hinder the functional activities of RANKL and promote the generation of osteoblasts and the apoptosis of osteoclasts [32, 33]. Therefore, the expression of OPG and RANKL in periodontal tissues plays an important role in regulating alveolar bone resorption [34]. Park et al. showed that HBD3-C15 could inhibit RANKL-induced osteoclast differentiation and disrupt the formation of the RANKL-induced podosome belt [35]. Studies have also shown that AuNPs cannot only suppress pre-osteoclast fusion induced by RANKL and macrophage colony stimulating factor (M-CSF), but also bring about significant downregulation of RANKL gene expression and the RANKL/OPG ratio [36, 37]. Our results demonstrated that AuNPs combined with hBD3 could inhibit the secretion of RANKL and increase the expression of OPG, which might reduce the absorption of alveolar bone.

There are still some limitations in the present study. Osteogenesis is regulated by a variety of cells, factors, and signaling pathways. In this study, we mainly focused on the changes in osteoclasts and the expression of RANKL and OPG in local tissue. However, there has been no in-depth study on the specific cells in the tissue that play roles in alleviating bone resorption and promoting osteogenesis after treatment with AuNPs and hBD3. The specific regulatory mechanisms of the osteogenic differentiation of different cells still need to be further explored.

Conclusions

Based on the development of nanomaterials and tissue engineering technology, the combination of AuNPs with hBD3 had a protective effect on the progression of experimental periodontitis in rats. We demonstrated that AuNPs combined with hBD3 could suppress osteoclastogenesis and alleviate the inflammatory destruction of periodontitis along with the promotion of bone repair in vivo. These findings suggested that AuNPs combined with hBD3 might be a novel biomedical material in periodontal tissue engineering and periodontitis treatment.

Methods

Experimental animals and groups

After being fed adaptively for 1 week, 25 female SD rats at the age of 5 weeks old were randomly divided into five groups (N = 5/groups) as follows: (1) NaCl group, NaCl group with no ligation; (2) NaCl + ligation group, rats with ligature-induced periodontitis alone; (3) hBD3 + ligation group, rats with ligature-induced periodontitis that were treated with hBD3; (4) AuNPs + ligation group, rats with ligature-induced periodontitis that were treated with AuNPs; and (5) AuNPs-hBD3 + ligation group, rats with ligature-induced periodontitis that were treated with AuNPs combined with hBD3. Reagents and configurations.

hBD3 was commercially available from Peprotech (Rocky Hill, NJ, USA), and AuNPs with a diameter of 45 nm were synthesized by adopting a chemical reduction method. The concentrations of AuNPs and hBD3 were used according to our published data [13, 14].

Rat ligature-induced experimental periodontitis model

The rats were anesthetized with pentobarbital sodium (Sigma-Aldrich; Merck Millipore, Darmstadt, Germany) at 50 mg/kg. The silk threads were soaked in medium containing P. gingivalis for 2 h ahead of time and were then used to ligate the bilateral maxillary second molars of the SD rats. The control group was treated with no ligation, and the ligated groups were treated with sterile silk thread. According to the groups, 100 μL of 5 μg/mL hBD3, 10 μM AuNPs, or 0.9% NaCl solution was injected into the mesial, central, and distal sides of the maxillary second molars; this process was repeated every 3 days. At the study endpoint, when the rats were 7 weeks old, they were euthanized, blood was collected from retro-orbital, and the maxillary bone, gums, and other tissues were collected and fixed in a 4% neutral paraformaldehyde solution.

Micro-CT scanning

The maxillary samples of the SD rats were soaked in a 4% paraformaldehyde solution and then were scanned by micro-CT with a Skyscan 1176 scanner (Bruker, Karlsruhe, Germany). The scanning layer thickness was 18 μm, the X-ray exposure time was 404 ms, the tube voltage was 70 kV, and the tube current was 353 μA. After scanning, 3D volume rendering technology from CTVox software was used to convert the 2D CT tomography images into 3D images proportionally and to reconstruct the images to measure the bone mineral density (BMD), bone volume (BV), and tissue volume (TV).

Detection of serum inflammatory factors

After the rats were anesthetized, the hair around the eyes was cut off, the eyeball was protruding out of the socket, a fine-walled Pasteur pipette (o.d. of 1–2 mm) was inserted into the corner of the eye socket underneath the eyeball, the tip was directed at a 45-degree angle toward the middle of the eye socket. Gentle downward pressure was applied and then released until the vein was broken and blood was visualized entering the pipette. When amounts of blood began filling the pipette, the Eppendorf tube was used to collect blood. After standing at room temperature for 2 h at 2000 × g and centrifuging at 4 °C for 10 min, the serum was transferred to a new centrifuge tube. ELISA kits (R&D Systems, Minneapolis, MN, USA) were used to detect the concentrations of TNF-α, IL-6, and IFN-γ.

Histological and immunohistochemical analysis

The maxillary samples were soaked in 10% ethylenediaminetetraacetic acid (EDTA) for 4 weeks, dehydrated with an ethanol gradient, and embedded in paraffin. The sections of 5 μm thickness were obtained from sagittal aspects of the second molars. The sections were selected including the mesial and distal roots of the second molar and their root bifurcation. The sections were started to retain from the simultaneous appearance of the roots and root bifurcation of the second molars, until the roots and root bifurcation of the second molars disappeared. Subsequently H&E and Masson staining, as well as the specific tartrate-resistant acid phosphatase (TRAP) staining, was used to evaluate bone resorption and osteoclast activity in the tissue (H&E, Masson, and TRAP staining kits were all obtained from Servicebio, Wuhan, China). The number of osteoclasts per square millimeter around the alveolar bone surface was counted and analyzed on the basis of the TARP staining images. Alkaline phosphatase (ALP) (antibody obtained from Huabio, Hangzhou, China, #ET1601-21, rabbit pAb), osteoprotegerin (OPG) (antibody obtained from Huabio, #EM1701-98, rabbit pAb), and receptor activator of NF-κB ligand (RANKL) (antibody obtained from Servicebio, Wuhan, China, #gb11235, rabbit pAb) expression levels in the periodontal tissues around maxillary second molars were measured by the immunohistochemical method. Stained sections were scanned using CaseViewer software (3Dhistech, Budapest, Hungary). Then, the quantitative analyses of ALP, OPG, and RANKL expression were performed with ImageJ software.

Statistical analysis

In our study, all statistical computations were performed using GraphPad Prism 6.0 software, and the experimental data of each group are expressed as the mean ± standard deviation (SD). The statistical significance was analyzed using one-way analysis of variance (ANOVA) followed by the Tukey post hoc test. When the P value < 0.05, the difference was considered statistically significant.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

AuNPs:

Gold nanoparticles

hBD3:

Human β-defensin 3

micro-CT:

Micro-computerized tomography

ELISA:

Enzyme-linked immunosorbent assay

ALP:

Alkaline phosphatase

OPG:

Osteoprotegerin

TRAP:

Tartrate-resistant acid phosphatase

RANKL:

Receptor activator of NF-κB ligand

TNF-α:

Tumor necrosis factor-α

IL-6:

Interleukin-6

References

  1. 1.

    Bartold PM. Lifestyle and periodontitis: the emergence of personalized periodontics. Periodontol 2000. 2018;78(1):7–11.

    Article  Google Scholar 

  2. 2.

    Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000. 2007;43:294–315.

    Article  Google Scholar 

  3. 3.

    Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44.

    Article  Google Scholar 

  4. 4.

    Teughels W, Feres M, Oud V, Martin C, Matesanz P, Herrera D. Adjunctive effect of systemic antimicrobials in periodontitis therapy: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(Suppl 22):257–81.

    Article  Google Scholar 

  5. 5.

    Sun X-C, Wang H, Li J-h, Zhang D, Yin L-Q, Yan Y-F, et al. Repair of alveolar cleft bone defects by bone collagen particles combined with human umbilical cord mesenchymal stem cells in rabbit. BioMed Eng Online. 2020. https://doi.org/10.1186/s12938-020-00800-4.

    Article  Google Scholar 

  6. 6.

    Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001;276(8):5707–13.

    Article  Google Scholar 

  7. 7.

    Lee PH, Chen MY, Lai YL, Lee SY, Chen HL. Human beta-defensin-2 and -3 mitigate the negative effects of bacterial contamination on bone healing in rat calvarial defect. Tissue Eng Part A. 2018;24(7–8):653–61.

    Article  Google Scholar 

  8. 8.

    Zhu M, Miao B, Zhu J, Wang H, Zhou Z. Transplantation of periodontal ligament cell sheets expressing human betadefensin3 promotes antiinflammation in a canine model of periodontitis. Mol Med Rep. 2017;16(5):7459–67.

    Article  Google Scholar 

  9. 9.

    Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R, Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev. 2012;41(7):2943–70.

    Article  Google Scholar 

  10. 10.

    Khan MA, Khan MJ. Nano-gold displayed anti-inflammatory property via NF-kB pathways by suppressing COX-2 activity. Artif Cells Nanomed Biotechnol. 2018;46(sup1):1149–58.

    Article  Google Scholar 

  11. 11.

    de Araujo RFJ, de Araujo AA, Pessoa JB, Freire Neto FP, da Silva GR, Leitao Oliveira AL, et al. Anti-inflammatory, analgesic and anti-tumor properties of gold nanoparticles. Pharmacol Rep. 2017;69(1):119–29.

    Article  Google Scholar 

  12. 12.

    Zhang Y, Wang P, Wang Y, Li J, Qiao D, Chen R, et al. Gold Nanoparticles promote the bone regeneration of periodontal ligament stem cell sheets through activation of autophagy. Int J Nanomedicine. 2021;16:61–73.

    Article  Google Scholar 

  13. 13.

    Ni C, Zhou J, Kong N, Bian T, Zhang Y, Huang X, et al. Gold nanoparticles modulate the crosstalk between macrophages and periodontal ligament cells for periodontitis treatment. Biomaterials. 2019;206:115–32.

    Article  Google Scholar 

  14. 14.

    Zhou J, Zhang Y, Li L, Fu H, Yang W, Yan F. Human beta-defensin 3-combined gold nanoparticles for enhancement of osteogenic differentiation of human periodontal ligament cells in inflammatory microenvironments. Int J Nanomedicine. 2018;13:555–67.

    Article  Google Scholar 

  15. 15.

    Gruber R. Osteoimmunology: inflammatory osteolysis and regeneration of the alveolar bone. J Clin Periodontol. 2019;46(Suppl 21):52–69.

    Article  Google Scholar 

  16. 16.

    Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745–59.

    Article  Google Scholar 

  17. 17.

    Nehls C, Bohling A, Podschun R, Schubert S, Grotzinger J, Schromm A, et al. (2020) Influence of disulfide bonds in human beta defensin-3 on its strain specific activity against Gram-negative bacteria. Biochim Biophys Acta Biomembr. 1862;8: 183273.

    Google Scholar 

  18. 18.

    Zhu M, Miao B, Zhu J, Wang H, Zhou Z. Expression and antimicrobial character of cells transfected with human betadefensin3 against periodontitisassociated microbiota in vitro. Mol Med Rep. 2017;16(3):2455–60.

    Article  Google Scholar 

  19. 19.

    Wang S, Yan C, Zhang X, Shi D, Chi L, Luo G, et al. Antimicrobial peptide modification enhances the gene delivery and bactericidal efficiency of gold nanoparticles for accelerating diabetic wound healing. Biomater Sci. 2018;6(10):2757–72.

    Article  Google Scholar 

  20. 20.

    Xiao Y, Zhang E, Fu A. Promotion of SH-SY5Y cell Growth by gold nanoparticles modified with 6-mercaptopurine and a neuron-penetrating peptide. Nanoscale Res Lett. 2017;12(1):641.

    Article  Google Scholar 

  21. 21.

    Shirazi AN, Paquin KL, Howlett NG, Mandal D, Parang K. Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery. Molecules. 2014;19(9):13319–31.

    Article  Google Scholar 

  22. 22.

    Peng LH, Huang YF, Zhang CZ, Niu J, Chen Y, Chu Y, et al. Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity. Biomaterials. 2016;103:137–49.

    Article  Google Scholar 

  23. 23.

    Rau LR, Huang WY, Liaw JW, Tsai SW. Photothermal effects of laser-activated surface plasmonic gold nanoparticles on the apoptosis and osteogenesis of osteoblast-like cells. Int J Nanomedicine. 2016;11:3461–73.

    Article  Google Scholar 

  24. 24.

    Afacan B, Ozturk VO, Pasali C, Bozkurt E, Kose T, Emingil G. Gingival crevicular fluid and salivary HIF-1alpha, VEGF, and TNF-alpha levels in periodontal health and disease. J Periodontol. 2019;90(7):788–97.

    Google Scholar 

  25. 25.

    Cardoso EM, Reis C, Manzanares-Cespedes MC. Chronic periodontitis, inflammatory cytokines, and interrelationship with other chronic diseases. Postgrad Med. 2018;130(1):98–104.

    Article  Google Scholar 

  26. 26.

    Naruishi K, Nagata T. Biological effects of interleukin-6 on gingival fibroblasts: cytokine regulation in periodontitis. J Cell Physiol. 2018;233(9):6393–400.

    Article  Google Scholar 

  27. 27.

    Edsall SC, Franz-Odendaal TA. A quick whole-mount staining protocol for bone deposition and resorption. Zebrafish. 2010;7(3):275–80.

    Article  Google Scholar 

  28. 28.

    Skottke J, Gelinsky M, Bernhardt A. In vitro co-culture model of primary human osteoblasts and osteocytes in collagen gels. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20081998.

    Article  Google Scholar 

  29. 29.

    Li K, Zhuang P, Tao B, Li D, Xing X, Mei X. Ultra-small lysozyme-protected gold nanoclusters as nanomedicines inducing osteogenic differentiation. Int J Nanomedicine. 2020;15:4705–16.

    Article  Google Scholar 

  30. 30.

    Kraus D, Deschner J, Jager A, Wenghoefer M, Bayer S, Jepsen S, et al. Human beta-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol. 2012;227(3):994–1003.

    Article  Google Scholar 

  31. 31.

    Udagawa N, Koide M, Nakamura M, Nakamichi Y, Yamashita T, Uehara S, et al. Osteoclast differentiation by RANKL and OPG signaling pathways. J Bone Miner Metab. 2021;39(1):19–26.

    Article  Google Scholar 

  32. 32.

    Walsh MC, Choi Y. Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Front Immunol. 2014;5:511.

    Article  Google Scholar 

  33. 33.

    Yasuda H. Discovery of the RANKL/RANK/OPG system. J Bone Miner Metab. 2021;39(1):2–11.

    Article  Google Scholar 

  34. 34.

    Belibasakis GN, Bostanci N. The RANKL-OPG system in clinical periodontology. J Clin Periodontol. 2012;39(3):239–48.

    Article  Google Scholar 

  35. 35.

    Park OJ, Kim J, Ahn KB, Lee JY, Park YJ, Kum KY, et al. A 15-amino acid C-terminal peptide of beta-defensin-3 inhibits bone resorption by inhibiting the osteoclast differentiation and disrupting podosome belt formation. J Mol Med. 2017;95(12):1315–25.

    Article  Google Scholar 

  36. 36.

    Zeng L, Geng H, Gu W, Ma S, Qin Y, Xia S, et al. Au Nanoparticles attenuate RANKL-induced osteoclastogenesis by suppressing pre-osteoclast fusion. J Nanosci Nanotechnol. 2019;19(4):2166–73.

    Article  Google Scholar 

  37. 37.

    Mahmoud NS, Mohamed MR, Ali MAM, Aglan HA, Amr KS, Ahmed HH. Osteoblast-based therapy-a new approach for bone repair in osteoporosis: pre-clinical setting. Tissue Eng Regen Med. 2020;17(3):363–73.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank the staff at the Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University for their kind help.

Funding

This work was supported by the National Natural Science Foundation Project (No. 81771078 and No. 81570982), Jiangsu Provincial Medical Innovation Team (No. CXTDB2017014), and the Nanjing Clinical Research Center for Oral Diseases (No. 2019060009).

Author information

Affiliations

Authors

Contributions

ZJ and YFH designed the study. YWR synthesized the AuNPs. ZJ did the model of experimental periodontitis with LLJ, CD, and XXT. LLJ had contributed to the data analysis as well. ZJ edited the manuscript and was responsible for the integrity of the data and the accuracy of the data analysis. YFH was involved in the revision of the manuscript. All the authors read and approved the final manuscript.

Corresponding author

Correspondence to Fuhua Yan.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Nanjing University (IACUC-2003041). This animal study was in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhou, J., Li, L., Cui, D. et al. Effects of gold nanoparticles combined with human β-defensin 3 on the alveolar bone loss of periodontitis in rat. BioMed Eng OnLine 20, 115 (2021). https://doi.org/10.1186/s12938-021-00954-9

Download citation

Keywords

  • Gold nanoparticles
  • hBD3
  • Periodontitis
  • Osteogenesis